Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01
Published October 22, 2025 · Recall initiated: October 7, 2025
Summary
FDA records drug Class II recall D-0029-2026, published October 22, 2025 and initiated October 7, 2025. Recalling firm: Rising Pharma Holding, Inc.; Status: Ongoing; Reported quantity: 2,064 100-count bottles; Lot: Lot # CS25070, exp. date 03/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
What to do
Voluntary: Firm initiated · Letter
Get an email if CARBIDOPA, LEVODOPA AND ENTACAPONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- Manufacturer
- Rising Pharma Holding, Inc.
- Distributor
- Distributed Nationwide in the USA
- UPC
- 0316571690015
- Lot
- Lot # CS25070, exp. date 03/31/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by:October 22, 2025
- FDAHaifa COLD SMOKED SALMON 8 OZ.October 22, 2025
- FDASucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging,October 22, 2025
- FDANOW Real Food Organic Unsalted Whole Raw Cashews, 10 oz. pouch, UPC 7 33739 07066 1 Product Code 7066October 22, 2025
- FDAEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,October 22, 2025
- FDASliced (1/4") green onions, refrigerated, packaged in plastic bag. Each case consist 5/6lbs. bag (net wt.October 22, 2025
Questions about this recall
Was Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01 recalled?
Yes. FDA published recall D-0029-2026 on October 22, 2025. Reported hazard: Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CARBIDOPA, LEVODOPA AND ENTACAPONE. UPC: 0316571690015.